An American neurologist and an Italian epidemiologist whose work revolutionized the treatment of multiple sclerosis on ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...

Tolebrutinib is an oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase inhibitor that modulates peripheral ...

Researchers from the Netherlands Institute for Neuroscience (NIN) have discovered new potential therapeutic targets for multiple sclerosis (MS). While current treatments prevent further damage, the ...

Two prominent scientists who study multiple sclerosis — Dr. Alberto Ascherio and Dr. Stephen Hauser — are co-winners of a ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with ...

Researchers at University College London (UCL) in the UK have developed MindGlide, an AI tool that evaluates magnetic ...

Researchers had known that there was something odd about the development of MS, and attributed it to the so-called hygiene ...

The actress boosts awareness of MS as the West Hollywood-based neurologist works to limit its effect on patients ...

MUSETTE trial was designed to determine whether a higher dose of the currently approved OCREVUS IV 600 mg would provide ...

Alberto Ascherio and Stephen Hauser were recognized for their work uncovering the role of B cells and Epstein Barr virus in ...

An American neurologist and an Italian epidemiologist whose work revolutionised the treatment of multiple sclerosis yesterday ...